Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lambin

Showing results (881-890 of 939) with videos related to

Pageof 94
Sort By:
Plos One|May 23, 2020
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapySimon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
Frontiers in Oncology|May 13, 2017
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers EraDavid Azria, Ariane Lapierre, Sophie Gourgou, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncologyRoberto Salgado, David B Solit, David L Rimm, et al.
Case Reports in Oncological Medicine|May 9, 2013
A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastasesAnthony C Nichols, Michelle Chan-Seng-Yue, John Yoo, et al.
BMC Cancer|August 19, 2016
A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patientsRuben T H M Larue, Lien Van De Voorde, Maaike Berbée, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma OutcomesTom van den Ende, Steven C Kuijper, Yousif Widaatalla, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 2, 2015
New ways to image and target tumour hypoxia and its molecular responsesLudwig J Dubois, Raymon Niemans, Simon J A van Kuijk, et al.
Plos One|July 30, 2020
Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapySimon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal CancerNicola Dinapoli, Brunella Barbaro, Roberto Gatta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2011
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCTM L Kimman, C D Dirksen, A C Voogd, et al.
Pageof 94

Showing results (881-890 of 939) with videos related to

Sort By:
Pageof 94
Plos One|May 23, 2020
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapySimon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
Frontiers in Oncology|May 13, 2017
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers EraDavid Azria, Ariane Lapierre, Sophie Gourgou, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncologyRoberto Salgado, David B Solit, David L Rimm, et al.
Case Reports in Oncological Medicine|May 9, 2013
A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastasesAnthony C Nichols, Michelle Chan-Seng-Yue, John Yoo, et al.
BMC Cancer|August 19, 2016
A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patientsRuben T H M Larue, Lien Van De Voorde, Maaike Berbée, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma OutcomesTom van den Ende, Steven C Kuijper, Yousif Widaatalla, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 2, 2015
New ways to image and target tumour hypoxia and its molecular responsesLudwig J Dubois, Raymon Niemans, Simon J A van Kuijk, et al.
Plos One|July 30, 2020
Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapySimon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal CancerNicola Dinapoli, Brunella Barbaro, Roberto Gatta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2011
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCTM L Kimman, C D Dirksen, A C Voogd, et al.
Pageof 94